Detalhe da pesquisa
1.
The National Lung Matrix Trial of personalized therapy in lung cancer.
Nature;
583(7818): 807-812, 2020 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32669708
2.
Publisher Correction: The National Lung Matrix Trial of personalized therapy in lung cancer.
Nature;
585(7826): E21, 2020 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32887973
3.
The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care.
Br J Cancer;
128(2): 161-164, 2023 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36599918
4.
Correction to: The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care.
Br J Cancer;
128(2): 399, 2023 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36697967
5.
Challenges in molecular testing in non-small-cell lung cancer patients with advanced disease.
Lancet;
388(10048): 1002-11, 2016 Sep 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27598680
6.
Protocol for the Tessa Jowell BRAIN MATRIX Platform Study.
BMJ Open;
12(9): e067123, 2022 09 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36378622
7.
Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial.
Lancet Respir Med;
10(3): 255-266, 2022 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34922649
8.
CATALYST trial protocol: a multicentre, open-label, phase II, multiarm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults.
BMJ Open;
11(11): e050202, 2021 11 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34764169
9.
Somatic cancer genetics in the UK: real-world data from phase I of the Cancer Research UK Stratified Medicine Programme.
ESMO Open;
3(6): e000408, 2018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30233821